Portal de Periódicos da CAPES

Malonyl-CoA and AMP-activated protein kinase (AMPK): possible links between insulin resistance in muscle and early endothelial cell damage in diabetes

2003; Portland Press; Volume: 31; Issue: 1 Linguagem: Inglês

10.1042/bst0310202

1470-8752

Neil B. Ruderman, José M. Cacicedo, Samar I. Itani, Nobuo Yagihashi, Asish K. Saha, J.M. Ye, K. Chen, Ming‐Hui Zou, David Carling, G. Boden, Richard A. Cohen, John F. Keaney, Edward W. Kraegen, Yasuo Ido,

Adipokines, Inflammation, and Metabolic Diseases

Based on available evidence, we would propose the following. (i) Excesses of glucose and free fatty acids cause insulin resistance in skeletal muscle and damage to the endothelial cell by a similar mechanism. (ii) Key pathogenetic events in this mechanism very likely include increased fatty acid esterification, protein kinase C activation, an increase in oxidative stress (demonstrated to date in endothelium) and alterations in the inhibitor κB kinase/nuclear factor κB system. (iii) Activation of AMP-activated protein kinase (AMPK) inhibits all of these events and enhances insulin signalling in the endothelial cell. It also enhances insulin action in muscle; however, the mechanism by which it does so has not been well studied. (iv) The reported beneficial effects of exercise and metformin on cardiovascular disease and insulin resistance in humans could be related to the fact that they activate AMPK. (v) The comparative roles of AMPK in regulating metabolism, signalling and gene expression in muscle and endothelial cells warrant further study.